Abstral
® (
fentanyl sublingual tablets) is a prescription opioid pain medication approved to manage breakthrough pain (intense flares of pain that "break through" regularly scheduled pain medication) in people with cancer who are already taking opioid pain medication around the clock for their persistent cancer pain. It comes in the form of a small tablet that is dissolved on the floor of the mouth, under the tongue.
Like other
fentanyl medications, Abstral is a Schedule II
controlled substance. Schedule II controlled substances are considered to have the highest abuse potential of all prescription medications. As a controlled substance, there are strict laws and regulations controlling this medication's sale and use.
Who Makes This Medication?
Abstral is manufactured by Novartis Consumer Health, Inc., for ProStrakan, Inc.
Abstral contains fentanyl, which is a strong opioid narcotic medication.
Fentanyl binds to the opioid mu-receptors throughout the body, producing many different effects. Some of these effects, such as pain relief, are desirable; other effects, such as slowing down the digestive tract, are undesirable and lead to side effects such as
constipation.
The effects of fentanyl include but are not limited to:
- Pain relief
- Drowsiness
- Changes in mood, including feelings of unease (dysphoria) or unusually pleasant feelings (euphoria)
- Cough suppression
- Slowed or shallow breathing
- Slowing of the digestive tract
- Pupil constriction
- Itching
- Physical dependence.
HealthSavvy Sign In
|
